Table 2.
Antibacterial activity of selected compounds toward resistant bacterial strains; results are in mg/mL; MIC—minimal inhibitory concentrations; MBC—minimal bactericidal concentration.
| Compounds | MRSA | P.a. | E.c. | |
|---|---|---|---|---|
| 5 | MIC | 0.09 | 0.18 | 0.09 |
| MBC | 0.18 | 0.36 | 0.18 | |
| 6 | MIC | 0.18 | 0.09 | 0.09 |
| MBC | 0.36 | 0.18 | 0.18 | |
| 8 | MIC | 0.36 | 0.18 | 0.09 |
| MBC | 0.72 | 0.36 | 0.18 | |
| 15 | MIC | 0.09 | 0.09 | 0.09 |
| MBC | 0.18 | 0.18 | 0.18 | |
| Streptomycin | MIC | 0.1 | 0.05 | 0.1 |
| MBC | / | 0.1 | 0.2 | |
| Ampicillin | MIC | / | 0.2 | 0.2 |
| MBC | / | / | / |
MRSA—Methicillin-resistant Staphylococcus aureus, E.c.—E. coli, P.a.—P. aeruginosa.